Data / Form D filings / Phoenix PharmaLabs Inc
Phoenix PharmaLabs Inc: Form D filing
Phoenix PharmaLabs Inc, a pharmaceuticals company in Woods Cross, UT, filed a Form D with the SEC in 2018. The latest, on November 7, 2018, reports an offering of $3.5 million with nothing sold yet.
Find out what Phoenix PharmaLabs Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 999 WEST 1500 SOUTH, BUILDING 600, Woods Cross, UT, 84087
- Phone
- (801) 420-0285
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Utah
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1755778
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John A Lawson | Executive Officer, Director, Promoter | |
| Timmy Chou | Executive Officer, Director, Promoter | |
| Lawrence Toll | Executive Officer, Director, Promoter | |
| Chris A Tew | Executive Officer, Director, Promoter | |
| William W Crossman | Executive Officer, Director, Promoter |
Every Form D from the week of Nov 5, 2018 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Phoenix PharmaLabs Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.